
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Peppermint leaf (Mentha piperita L.) contains menthol and rosmarinic acid as primary bioactive compounds that provide clinically validated digestive and respiratory benefits. Menthol works by antagonizing L-type calcium channels and relaxing smooth muscle, while phenolic compounds like rosmarinic acid deliver antioxidant and anti-inflammatory effects.

Reported Benefits (Provisional)
Origin & History

Peppermint leaf (Mentha piperita) is a hybrid mint, a cross between watermint and spearmint, native to Europe and the Middle East. It is widely cultivated globally for its aromatic and medicinal properties. This botanical is highly valued in functional nutrition for its significant digestive, respiratory, and anti-inflammatory benefits.
Research Narrative (Provisional)
Extensive scientific research, including human clinical trials and meta-analyses, confirms Peppermint leaf's efficacy for digestive health, particularly in relieving IBS symptoms. Studies also support its anti-inflammatory, analgesic, and antimicrobial properties, validating its traditional uses for respiratory and pain management.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Menthol, Rosmarinic acid, Flavonoids, Polyphenols, Essential oils - Vitamin C
Reported Mechanism (Provisional)
Menthol antagonizes L-type calcium channels via dihydropyridine binding sites, reducing peak current amplitude and relaxing gastrointestinal smooth muscle. Rosmarinic acid and flavonoids like luteolin inhibit pro-inflammatory cytokines including TNF-α and IL-6. Phenolic compounds provide antioxidant activity through hydrogen atom transfer and single electron transfer mechanisms, with superior DPPH radical scavenging compared to other mint species.
Clinical Narrative (Provisional)
Human clinical trials focus primarily on peppermint oil rather than leaf preparations, with enteric-coated peppermint oil (180-225 mg, 1-2 capsules daily) showing 40-50% reduction in IBS symptoms over 4-8 week periods. Meta-analyses confirm peppermint oil efficacy for IBS, with one trial demonstrating 75% symptom improvement versus 38% placebo response. Clinical evidence for peppermint leaf tea specifically is limited, with most supporting data derived from in vitro studies showing α-glucosidase inhibition (IC₅₀ 5.92 µg GAE/mL) and animal models. Human trials on leaf preparations are needed to validate traditional uses.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







